Our advanced testing options give you personalized insights into your nutritional status, energy levels, and overall well-being, enabling you to make informed decisions for a healthier, happier life
Clinical Evidence on Semaglutide and Cardiac Function The SUSTAIN trials, which tracked thousands of patients over 23 years, documented semaglutide's cardiovascular effects in detail
The third is investigational, and Velora supplies it strictly for in-vitro research as GLP-3 RT
Ethics declarations Sources of support The research reported in this publication was supported by the National Institute of Arthritis and Musculoskeletal and Skin Diseases of the National Institutes of Health under award numbers UH2AR076719, UH3AR076719, U19AR076737, and F32AR081139, and through R01AR070198 and R01AR063705
Trials have initiated treatment at a lower dose, with scheduled increases every four weeks to allow for monitoring of tolerability and side effects